| Literature DB >> 23442980 |
Ehsan Karimi1, Ehsan Oskoueian, Rudi Hendra, Armin Oskoueian, Hawa Z E Jaafar.
Abstract
Citrus plants are known to possess beneficial biological activities for human health. In addition, ethnopharmacological application of plants is a good tool to explore their bioactivities and active compounds. This research was carried out to evaluate theEntities:
Mesh:
Substances:
Year: 2012 PMID: 23442980 PMCID: PMC6268598 DOI: 10.3390/molecules17021203
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Total phenolic and flavonoids content of Citrus aurantium bloom.
| Solvent | Phenolic Content 1 | Flavonoid Content 2 |
|---|---|---|
| Ethanol | 4.55 ± 0.005 b | 3.83 ± 0.05 b |
| Water | 3.93 ± 0.58 c | 1.88 ± 0.01 c |
| Methanol | 4.83 ± 0.05 a | 4.11 ± 0.05 a |
1 mg gallic acid equivalent/g DW; 2 mg rutin equivalent/g DW; n = 3. Means within the same column with different letters are significantly different (p < 0.05).
Figure 1The RP-HPLC chromatogram of flavonoid compounds in methanolic extract of Citrus aurantium bloom. Identified compounds: Rutin, naringin and quercetin.
Figure 2The RP-HPLC chromatogram of phenolic compounds in methanolic extract of Citrus aurantium bloom. Identified compounds: Gallic acid, pyrogallol, syringic acid and caffeic acid.
Phenolic compounds of methanolic extract of Citrus aurantium bloom.
| Sample | Phenolic contents (µg/g dry sample) | |||||
|---|---|---|---|---|---|---|
| Gallic acid | Pyrogallol | Salicylic acid | Caffeic acid | Vanillic acid | Syringic acid | |
| 212.42 ± 0.02 | 541.27 ± 0.03 | ND | 249.95 ± 0.05 | ND | 269.04 ± 0.05 | |
ND: not detected.
Flavonoid compounds of methanolic extract of Citrus aurantium bloom.
| Sample | Flavonoid contents (µg/g dry sample) | |||||
|---|---|---|---|---|---|---|
| Apigenin | Kaempferol | Myricetin | Naringin | Quercetin | Rutin | |
| ND | ND | ND | 688.11 ± 0.05 | 185.37 ± 0.11 | 362.85 ± 0.01 | |
ND: not detected.
Figure 3Chromatogram of flavonoids mixture of the standards detected at 350 nm by RP-HPLC: 11.76-rutin, 14.12-naringin, 17.67-myricetin, 21.854-quercetin, 24.85-apigenin and 25.909-kaempferol.
Figure 4Free radical scavenging activity of Citrus aurantium extracts using different solvents by 1,1-diphenyl-2-picrylhydrazyl radicals. n = 3.
Figure 5The free radical scavenging of Citrus aurantium bloom extracts using different solvents and reference antioxidants at 300 μg/mL.
FRAP activity of Citrus aurantium extracts using different solvents (methanol, boiling waterand ethanol). BHT, α-tocopherol and vitamin C were used as positive controls.
| Solvent used for Extraction | FRAP (300 μg/mL) | |
|---|---|---|
| Methanol | 51.7 ± 37.3 d | |
| Water | 43.5 ± 23.4 f | |
| Ethanol | 47.6 ±18.7 e | |
| BHT | 89.5± 11.2 c | |
| Control | α-tocopherol | 92.9 ± 25.4 b |
| Vitamin C | 96.1 ± 41.2 a |
All analyses were the mean of triplicate measurements ± standard deviation. Results expressed in percent of antioxidant power at 300 μg/mL. Means not sharing a common letter within a column were significantly different at p ≤ 0.05.
Figure 6Effect of C. aurantium extracts at various concentration on the production of NO by LPS/IFN-γ stimulated RAW 264.7 cells. Each bar represents the mean ± standard error of mean from three independent experiments. *** p < 0.0001 indicates a significant difference from the LPS/IFN-γ stimulated cells analyzed by using the Dunnett’s Comparison Test.
Figure 7Effect of the C. aurantium extracts on cell viability of RAW 264.7 cells. Each bar represents the mean ± standard error of mean from three independent experiments.
Figure 8Effect of crude methanolic extract of Citrus blooms on Chang liver, MCF-7, MDA-MB 231 and HT-29 cells survival. All values represent the mean ± S.E.M from three independent experiments. *** p < 0.001, ** p < 0.01 and * p < 0.1 indicate significant difference compared to the untreated control group.
The IC50 values of extracts and positive control on Chang liver, MCF-7, MDA-MB 231 and HT-29 cell lines.
| Sample | IC50 value (μg/mL) | |||
|---|---|---|---|---|
| Chang liver | MCF-7 | MDA-MB 231 | HT-29 | |
| >200 | 152.34 ± 0.75 | 49.74 ± 0.75 | 96.23 ± 0.75 | |
| Tamoxifen | 45.07 ± 2.59 | 17.31 ± 0.93 | 17.51 ± 0.25 | 18.11 ± 0.89 |
Figure 9Effect of tamoxifen as a positive control on Chang liver, MCF-7, MDA-MB 231 and HT-29 cells survival. All values represent the mean ± S.E.M from three independent experiments. *** p < 0.001, ** p < 0.01 and * p < 0.1 indicate significant difference compared to the untreated control group.